2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theGestational Diabetes Market?

The escalating number of individuals with obesity is projected to fuel the expansion of the gestational diabetes market. Those considered as part of the obese population have a body mass index (BMI) of 30 or more, suggesting an excessive level of body fat that could lead to serious health problems. The rise in obesity is attributed to a blend of inactive lifestyles, greater intake of high-calorie, processed foods, genetic factors, and restricted availability of nutritious food and exercise alternatives. Treating gestational diabetes is vital among obese individuals since their heightened risk of insulin resistance and excessive weight gain during pregnancy might result in complications for both mother and child if not properly controlled. For example, data from the World Health Organization, a Switzerland-based international entity, revealed in March 2024 that roughly 1 out of 8 individuals worldwide were dealing with obesity in 2022. These figures included 2.5 billion adults aged 18 and over who were overweight, including 890 million people with obesity. Among these adults, 43% were overweight, and 16% had obesity. Moreover, 37 million children below 5 years old were overweight, and more than 390 million children and teenagers between 5 and 19 years old were overweight, with 160 million of them dealing with obesity. Therefore, the rising number of obese individuals is propelling the gestational diabetes market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp

#What Long-Term Growth Rate is Expected for theGestational Diabetes Market Between 2025 and 2034?

The market for gestational diabetes has witnessed significant expansion in the recent past. It is predicted to escalate from $8.37 billion in 2024 to $9.14 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The past growth can be linked to the amplified risk of diabetes, better precision in blood glucose level measurements, a rise in the number of insurance providers, and an increase in the number of diabetic patients and growth of the diabetes-stricken population.

It is anticipated that the gestational diabetes market will experience significant growth in the upcoming years, expanding to a value of $12.90 billion in 2029 with a compound annual growth rate of 9.0%. Several factors contribute to this expected growth through the forecast period. These include a surge in obesity rates, the rising adoption of cloud-based project systems, and an increase in the use of associated devices and apps. Other contributing factors include a higher incidence of diabetes due to unhealthy living habits, greater public awareness of health issues, and increasing diabetes prevalence rates. Major trends predicted for the forecast period encompass digital apps for diabetes management, closed-loop control systems, diabetes management technology, enzymatic technology and groundbreaking medical technologies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20818

What Are the Latest Innovations Influencing theGestational Diabetes Market?

Leading firms in the gestational diabetes market are concentrating their efforts on the creation of technologically advanced goods, such as diagnostic kits for gestational diabetes. These kits aim to offer a swift, accurate, and convenient means of early detection. A gestational diabetes diagnostic kit— a medical device— is used to gauge blood glucose concentrations and pinpoint abnormal glucose tolerance in expectant mothers, thus facilitating early detection and management of the disease. DirectSens GmbH, a biotech company based in Austria, for example, launched the XpressGT RUO kit in August 2024. This kit was created to diagnose gestational diabetes, endometriosis, insulin resistance, and liver disease. It accurately detects 2-hydroxybutyrate (2-HB) levels existing in venous blood, a substance naturally created by the liver during its typical functions. Elevated 2-HB levels are linked to heightened reductive stress, which is associated with a range of obesity-related and endocrine disorders, including insulin resistance. This kit is compatible with any existing clinical analyzer, and it delivers results in only 8 minutes— proving to be a quick and effective diagnostic tool.

Who Are the Major Industry Players Accelerating Growth in theGestational Diabetes Market?

Major companies operating in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

Which Primary Segments of the Gestational Diabetes Market Are Driving Growth and Industry Transformations?

The gestational diabetes market covered in this report is segmented –

1) By Types: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20818&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theGestational Diabetes Market?# Market?

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Gestational Diabetes Market 2025, By The Business Research Company:

Diabetes Care Devices Opportunities And Strategies Global Market Report 2025

https://thebusinessresearchcompany.com/report/diabetes-care-devices-market

Global Diabetes Therapies Opportunities And Strategies Global Market Report 2025

https://thebusinessresearchcompany.com/report/diabetes-therapies-market

Global Digital Diabetes Management Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: